Tags

Type your tag names separated by a space and hit enter

[SARS-CoV-2 vaccines].
Ugeskr Laeger. 2021 03 08; 183(10)UL

Abstract

Control of the ongoing coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) will require one or more vaccines. Currently, numerous SARS-CoV-2 vaccines are in either pre-clinical or clinical development. Twenty are in fase III development. In this review we summarise available safety and efficacy data of two RNA based vaccines, two non-replication competent vector-based vaccine, one inactivated whole-virus vaccine, and one subunit. All being either approved or nearing approval.

Authors+Show Affiliations

thomas.lars.benfield@regionh.dk.No affiliation info available

Pub Type(s)

Journal Article
Review

Language

dan

PubMed ID

33734065

Citation

Benfield, Thomas Lars, and Jannik Helweg-Larsen. "[SARS-CoV-2 Vaccines]." Ugeskrift for Laeger, vol. 183, no. 10, 2021.
Benfield TL, Helweg-Larsen J. [SARS-CoV-2 vaccines]. Ugeskr Laeger. 2021;183(10).
Benfield, T. L., & Helweg-Larsen, J. (2021). [SARS-CoV-2 vaccines]. Ugeskrift for Laeger, 183(10).
Benfield TL, Helweg-Larsen J. [SARS-CoV-2 Vaccines]. Ugeskr Laeger. 2021 03 8;183(10) PubMed PMID: 33734065.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [SARS-CoV-2 vaccines]. AU - Benfield,Thomas Lars, AU - Helweg-Larsen,Jannik, PY - 2021/3/18/entrez PY - 2021/3/19/pubmed PY - 2021/3/26/medline JF - Ugeskrift for laeger JO - Ugeskr Laeger VL - 183 IS - 10 N2 - Control of the ongoing coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) will require one or more vaccines. Currently, numerous SARS-CoV-2 vaccines are in either pre-clinical or clinical development. Twenty are in fase III development. In this review we summarise available safety and efficacy data of two RNA based vaccines, two non-replication competent vector-based vaccine, one inactivated whole-virus vaccine, and one subunit. All being either approved or nearing approval. SN - 1603-6824 UR - https://www.unboundmedicine.com/medline/citation/33734065/[SARS_CoV_2_vaccines]_ L2 - http://ugeskriftet.dk/videnskab/V01210052 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.